TGFB1 and neoplasm: As such, we speculate that the appearance of ilCAFs upon TGFβ-neutralization may be a contributing factor in potentiating anti-tumor immunity and responsiveness to checkpoint inhibition therapy through facilitating either enhanced infiltration or activation of cytotoxic T cells.